This Grand Opening marks the introduction of the NULISA™ platform at Amsterdam UMC and brings together an international group of researchers to discuss advances in ultra‑sensitive proteomics and biomarker research.

The programme combines a technical overview of the NULISA™ technology with scientific perspectives from leading investigators, including Prof. Monique Breteler (DZNE), Prof. Jonathan Rohrer (UCL), Prof. Amy Fu (Hong Kong University of Science and Technology), and Dr. Gemma Salvadó (Barcelonaβeta & Lund University), alongside contributions from Amsterdam UMC researchers.

Across the afternoon, speakers will highlight current applications, emerging biological insights, and the relevance of high‑sensitivity protein detection across neurology, immunology, and translational research. The meeting concludes with a keynote lecture from Amsterdam UMC, followed by discussion and informal exchange during the closing reception.

Program

13:00 – 13:15 Welcome & opening, Prof. Charlotte Teunissen, Amsterdam UMC

13:15 – 14:00 Introduction to NULISA technology: A new ultra-highly sensitive proteomics platform for profiling low abundant fluid-based biomarker, Mathias Holpert, Alamar Biosciences

14:00 – 14:30 Plasma and CSF proteomic signatures related to Alzheimer’s, α synuclein, or vascular pathologies and clinical decline, Dr. Gemma Salvadó, Barcelona Beta & Lund University

14:30 – 15:00 Proteomics profiling of healthy and unhealthy brain ageing in the Rhineland study, Prof. Monique Breteler, DZNE

15:00 – 15:30 Coffee break

15:30 – 15:50 NULISA analysis in genetic frontotemporal dementia: a study on the GENetic FTD Initiative, Prof. Jonathan Rohrer, UCL

15:50 – 16:15 Stratum Corneum Biomarkers in Dermatological Research: Potential and Methodological Challenge, Dr. Sanja Kezic, Amsterdam UMC

16:15 – 16:40 Blood Proteomic Analysis Using Ultra-sensitive Assays: Insights for the Accurate Classification and Staging of Alzheimer’s Disease Pathology, Prof. Amy Fu, Hong Kong University of Science and Technology

16:40 – 17:20 KEY LECTURE ‘The Amsterdam experience: reliable measurement of biomarkers for dementias and multiple sclerosis using NULISA’, Prof. Charlotte Teunissen, Amsterdam UMC

17:20 – 18:30 Closing remarks followed by reception